
Join to View Full Profile
1959 Ne Pacific StSeattle, WA 98195
Phone+1 206-598-4294
Dr. Gore is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. John Gore is a urologist and urologic oncologist in Seattle, WA and is affiliated with multiple hospitals in the area, including UW Medicine/University of Washington Medical Center, UW Medicine/Harborview Medical Center, and the Fred Hutchinson Cancer Center. He received his medical degree from Baylor College of Medicine and has been in practice 16 years. He is experienced in bladder cancer, kidney cancer, adrenal tumors, and robotic surgery.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Urology, 2001 - 2007
Baylor College of MedicineClass of 2001
Certifications & Licensure
MT State Medical License 2022 - 2028
ID State Medical License 2022 - 2027
AK State Medical License 2022 - 2026
WA State Medical License 2009 - 2026
CA State Medical License 2003 - 2012
American Board of Urology Urology
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
Clinical Trials
- Prospective Clinical Utility Study to Assess the Impact of Decipher on Treatment Decisions After Surgery Start of enrollment: 2014 May 01
Publications & Presentations
PubMed
- Treatment Selection for Non-Muscle-Invasive Bladder Cancer in an Emerging Treatment Era: A Patient Preference Study.Angela B Smith, John L Gore, Stephanie Chisolm, Patrick Squires, Haojie Li
Urology. 2026-02-11 - 2 citationsTwelve-Month Results From the CISTO Study Comparing Radical Cystectomy Versus Bladder-Sparing Therapy for Recurrent High-Grade Non-Muscle-Invasive Bladder Cancer.John L Gore, Erika M Wolff, Michael G Nash, Bryan A Comstock, Scott M Gilbert
Journal of Clinical Oncology. 2026-02-01 - 1 citationsMuscle-Invasive Bladder Cancer Treatment Selection in an Emerging Treatment Era: A Patient Preference Study.Angela B Smith, John L Gore, Stephanie Chisolm, Patrick Squires, Haojie Li
Urology. 2025-12-01
Authored Content
- Does the Diagnosis of Bladder Cancer Lead to Higher Rates of Smoking Cessation? Findings from the Medicare Health Outcomes SurveyMarch 2019
Press Mentions
Fred Hutch Launches Surgical Oncology Division, Names Inaugural LeaderApril 1st, 2026
The CISTO Study: Radical Cystectomy or Bladder-Sparing Therapy for Recurrent NMIBCMarch 12th, 2026
Cystectomy Matches Bladder Sparing for Function in Bladder Cancer, Study FindsFebruary 5th, 2026
Grant Support
- Mentored Urology Research ExperienceUNIVERSITY OF WASHINGTON2025–2030
- BEST CARE for Recurrent NMIBC: BladdEr-Sparing Therapy and Cystectomy As TREatmentsUNIVERSITY OF WASHINGTON2024–2029
Committees
- Member, Committee on Appropriateness Criteria, Expert Panel on Urologic Imaging, American College of Radiology 2015 - Present
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









